Aetna Healthcare has agreed to reimburse Helius Medical Technologies’ PoNS device, short for Portable Neuromodulation Stimulator, which uses electrical stimulation to improve walking in people with multiple sclerosis (MS). The policy covers PoNS at an out-of-network negotiated price of $18,350, making Aetna, one of the largest private health…

Enrollment is now complete in the twin Phase 3 clinical trials testing Immunic Therapeutics‘ oral small molecule vidofludimus calcium in adults with relapsing forms of multiple sclerosis (MS). ENSURE-1 (NCT05134441) has enrolled 1,121 patients and ENSURE-2 (NCT05201638) has enrolled 1,100 patients at more than 100…

My family and I just returned from a vacation to the place I wrote about in my very first column for Multiple Sclerosis News Today, only not to the same house. I can’t make it up and down the stairs there anymore, so my wife found us a wheelchair-accessible…

Children with pediatric-onset multiple sclerosis (POMS) experience biological aging at a faster rate than children without the disease, a study shows. “We found evidence that children living with MS experience accelerated biological aging,” Jennifer Graves, MD, PhD, senior author of the study at the University of California, San Diego,…